The largest database of trusted experimental protocols
> Procedures > Health Care Activity > Clinical Governance

Clinical Governance

Clinical governance is a framework for healthcare organizations to ensure the quality and safety of patient care.
It involves a systematic approach to maintaining and improving standards of clinical practice, with a focus on accountability, transparency, and continuous improvement.
Key elements of clinical governance include clinical audit, risk management, staff education and training, and the use of evidence-based practices.
By implementing effective clinical governance, healthcare providers can enhance patient outcomes, reduce adverse events, and promote a culture of excellence in service delivery.
This holistic approach helps organizations deliver high-quality, safe, and efficient care to the communities they serve.

Most cited protocols related to «Clinical Governance»

Data from consecutive patients admitted to the cardiac intensive care unit (CICU) following cardiac surgery at Wythenshawe Hospital (part of Manchester University NHS Foundation trust) were collected prospectively between January 2013 and May 2015. Wythenshawe Hospital is a tertiary centre for adult cardiac surgery, cardiothoracic transplantation and mechanical circulatory support as a bridge to cardiac transplantation or recovery. Patients requiring RRT preoperatively and those with no preoperative creatinine values were excluded as shown in Fig. 1. Patients who received mechanical circulatory support were excluded from length of stay (LOS) analyses as their CICU stay was prolonged while awaiting definitive treatment. All data were collected as part of the Vascular Governance North West (VGNW) database and processed according this project’s protocols and ethical approvals.

Flow chart for inclusion of patients in analyses. RRT = renal replacement therapy, sCR = serum creatinine result, MCS = mechanical circulatory support, PLOS = prolonged length of stay

Serum creatinine concentration was usually measured daily and all available results were extracted from the hospital’s pathology laboratory database. Our institution’s laboratory measures creatinine using techniques based on Jaffe chemistry with a total imprecision of < 6%. Every creatinine value for each patient was analysed and both relative and absolute increases in creatinine were used to classify AKI stages according to the KDIGO criteria (Table 1). The relative increases were calculated using the most recently recorded preoperative level as the baseline value. Urine output was recorded hourly on the CICU electronic patient record. Where the hourly value was recorded as none or zero, this value was accepted whereas when no value was entered for a given hour the next volume of urine recorded was divided equally by the number of blank hours prior to this recording. Whenever urine output fell below the thresholds in the KDIGO criteria, the time and appropriate stage of AKI was recorded. The need for RRT and postoperative LOS on CICU were identified from the electronic patient record. Serum creatinine concentration and urine output measurements recorded after initiation of RRT were not included in analyses as both are influenced heavily by RRT itself.
The hospital clinical governance database recorded 2-year all-cause mortality and the preoperative comorbidity, urgency and complexity of surgery as measured by the logistic EuroSCORE [16 (link)]. Prolonged LOS was defined as a CICU stay longer than 120 h for cardiac transplant patients or > 72 h for all other patients.
Full text: Click here
Publication 2018
Adult Blood Vessel Cardiovascular System Clinical Governance Creatinine Heart Transplantation Operative Surgical Procedures Patients Serum Surgical Procedure, Cardiac Transplantation Urine
The SMILE project will apply an observational prospective study design to follow a cohort of socioeconomically-diverse South Australian newborns and their primary care-givers (mothers will be used in this paper from here on), from birth until they reach toddler age. A multivariable, multilevel approach will be applied to data collection and analysis. The timeline and main groups of outcome and explanatory variables are outlined in Table 1.
The project has received ethical approval from the Southern Adelaide Clinical Human Research Ethics Committee (HREC # 50.13, approval date: 28 Feb 2013), the South Australian Women and Children Health Network (HREC # HREC/13/WCHN/69, approval date: 7 Aug 2013) and clinical governance clearance from the three participating maternity hospitals in Adelaide, Australia.
The study participant recruitment has commenced since July 2013 and is expected to last 12 months. The 3-month and 6-month data collection is ongoing.
Full text: Click here
Publication 2014
Childbirth Children's Health Clinical Governance Ethics Committees, Research Homo sapiens Infant, Newborn Mothers TimeLine Woman
The results of the systematic review of the literature on components of institutional care have been published elsewhere [10 (link)]. Eight domains of care were identified: living conditions; interventions for schizophrenia; physical health; restraint and seclusion; staff training and support; therapeutic relationship; autonomy and service user involvement; and clinical governance. The results of the Delphi exercise have also been previously reported [11 (link)] and eleven domains of care were identified: social policy and human rights; social inclusion; self management and autonomy; therapeutic interventions; governance; staffing; staff attitudes; therapeutic environment; post-discharge care; carers; physical health care [11 (link)]. Collation of each country's care standards by HK and TT identified seven domains: living environment; mental and physical health; therapeutic relationship; service users' rights and autonomy; service user involvement; staff training and support; clinical governance. The project steering committee (PSC) reviewed these findings and agreed on nine domains for inclusion in the toolkit (Living Environment; Treatments and Interventions including restraint and seclusion; Therapeutic Environment; Self-management and Autonomy; Social Policy, Citizenship and Advocacy; Clinical Governance; Social Interface; Human Rights; and Recovery Based Practice). These were further reviewed and agreed by an international panel of experts in social care, mental health rehabilitation, recovery based practice, service user experience, disability rights, international mental health law, international mental health policy and care standard setting.
Toolkit items for assessment of these domains were generated by the UK centres. The toolkit was designed to be completed by the manager of the facility since we were aware, due to the complexity of their mental health problems, that only some service users would have the capacity to complete such a measure. However, service users' experiences of care were assessed in a later Phase of the project to investigate the association between unit manager toolkit ratings and service user reports. Where possible, toolkit items were worded to avoid revealing which answer would lead to a higher quality rating. A mix of question formats was used (Likert scales, ordered categories, quantitative responses, binary responses, lists of yes/no's summed to create quantitative responses, and vignettes that asked the respondent to generate answers which were "checklisted" by the researcher and summed to give a quantitative response). The varied format of questions aimed to increase the accuracy of responses by avoiding a response set and make the toolkit more interesting to complete. The draft toolkit was reviewed by the PSC and the international expert panel and further questions were added if there was evidence for their inclusion from Phase 1 or if they appeared highly relevant across countries.
The toolkit was translated in each country and back translated by someone independent of the project. Back translations were reviewed at the lead centre in the UK and amendments agreed with each country. The toolkit was piloted in each country in one or two facilities. A training session was attended by all researchers involved in data collection to ensure clarity of understanding of all items and their scoring.
Full text: Click here
Publication 2011
Clinical Governance Disabled Persons Mental Health Patient Discharge Physical Examination Psychiatric Rehabilitation Respiratory Diaphragm Schizophrenia Self-Management Staff Attitude Therapeutics
KSSAAT previously used HEMS paramedic dispatchers (HPD) working on a dedicated dispatch desk in the EOC of the local ambulance service to activate the helicopter and its crew. Since January 2016, due to rota constraints and the availability of HEMS paramedics, it was no longer possible to fully cover the HEMS dispatch desk with a designated HEMS paramedic. Other means of specialist dispatch were therefore explored and the trust began training non-clinically trained dispatchers (NCDs) to work on the HEMS dispatch desk. All NCDs came from an ambulance dispatch background, with all candidates having extensive experience of working an ambulance control room. This study compares a total of 20 individual HPDs to 5 NCDs.
At the time of the study, all the NCDs came from a background working in the ambulance service EOC, dispatching land ambulances. As part of their HEMS dispatch training they were put through an induction course, followed by a four-week development period, starting with observation of the dispatch desk progressing to peer supervised practice and culminating in a sign-off assessment undertaken by an operational manager. The NCDs were aided by a bespoke tasking algorithm, devised by the KSSAAT team. The algorithm was based on expert opinion and internal consensus. This algorithm classifies HEMS dispatch into Grade 1 and Grade 2 dispatches for HEMS, based on mechanism of injury, clinical condition of the patient and geographical location. The specifics of the HEMS tasking criteria are shown in Fig. 1. The algorithm is paper based. Whilst listening to the incoming emergency call, dispatchers aim to rapidly identify either one (from Grade 1 criteria list) or two (from Grade 2 criteria list). If these are positively identified, HEMS is dispatched. Grade 1 should be dispatched within 5 min and Grade 2 within 10 min of receipts of 112/999 call.

KSSAAT HEMS tasking criteria used by non-clinical HEMS dispatchers. Grade 1 dispatch requires a single trigger to be met. Grade 2 dispatch requires two triggers to be met

In addition, NCDs were fully integrated into the KSSAAT Clinical Governance system. This includes receiving feedback on individual missions, attending Clinical Governance days (CGD) and receiving on-going training. CGDs are held every 2 weeks with dispatchers attending to partake in clinical case reviews. On average, 10–12 missions are reviewed on each CGD. Dispatchers attend a 1-h update/training session as part of each CGD and share experience with the other dispatchers. Peer review of dispatchers occurs 1–2 times per month by having a member of the KSSAAT senior management team undertake a dispatch shift with them.
In order to investigate any association between type of dispatcher and accurate dispatch, a service evaluation of incidents attended by the KSSAAT was undertaken as a prospectively planned project.
Full text: Click here
Publication 2018
Ambulances ARID1A protein, human Clinical Governance Emergencies Granulomatous Disease, Chronic, X-Linked Hematoporphyrin Derivative Hemorrhage Injuries Metin Paramedical Personnel Patients Peer Review Precipitating Factors
This cross-sectional study was conducted among cardiac clinic attendees within the South–West Regional Health Authority (SWRHA) of Trinidad and Tobago between 1 July 2012 and 31 August 2012. Quota sampling (i.e. successive sampling until the size of the sample is achieved) was used to select the participants. A total of 329 patients was the predetermined sample size required to estimate with a 5% margin of error the percentage of public cardiac clinic patients who use CAM [23 ]. To be eligible for participation, patients could not be confused (i.e. display problems with cognition or behaviour), as assessed by the student research assistant; had to be able to communicate verbally or in writing; and had to give consent. The data collection instrument was a self-completed questionnaire of 33 questions: seven questions on demographics; two questions on present cardiac condition; and the remaining questions on various aspects of CAM usage such as types, experiences, reasons, benefits, influences, effects and consequences, source, and access of CAM. Two medical students assisted participants who had difficulty understanding questions or who required clarification of questions.
Statistical analysis was conducted using SPSS, version 20 (Chicago, IL, USA) using descriptive methods and inferential methods. The descriptive methods included frequency distribution tables and graphs. Inferential methods included tests of equality of proportions, chi-squared tests of association between selected sociodemographic and other attribute variables and CAM use (e.g. Fisher’s exact test and McNemar’s test of paired proportions). Binary logistic regression was used to identify factors associated with CAM use among patients. Eight independent variables were used such as sex, marital status, ethnicity, educational level, employment status, religion, religiosity, and area of residence. All hypotheses were tested at the 5% level of significance. Ethical approval was obtained from the Clinical Governance and Ethics Committee of South–West Regional Health Authority on 25 May 2012.
Full text: Click here
Publication 2015
Clinical Governance Cognition Ethnicity Heart Heart Diseases Patients Regional Ethics Committees Student Students, Medical

Most recents protocols related to «Clinical Governance»

As primarily a retrospective service evaluation, the exploration has been registered and approved with Surrey and Borders Partnership NHS Foundation Trust clinical governance procedures (AU/002/10/2021). Service user/parental consent was obtained for each individual attending the National FASD Specialist Clinic for their anonymised data to be used in such evaluations to aid learning and to develop the clinic further. From all the cases seen in the National FASD Specialist Clinic since its origin in 2009, only a few cases declined to allow their data to be used for such purposes and were not included. Specific numbers for those declining are not held in the database. The database is ongoing and continues to develop.
Full text: Click here
Publication 2023
ARID1A protein, human Clinical Governance Fetal Alcohol Syndrome Vision
There were three main interventions: a VRIII Prescribing Checklist (online supplemental appendix 1), education of junior doctors and ward staff, and eMeds system updates. The Prescribing Checklist contains a list of the indications for perioperative VRIII and a step-by-step guide through the prescribing tasks that must be completed to safely commence VRIII. This was developed in a collaborative approach by doctors and pharmacists based on local National Health Service Trust and JBDS-IP guidelines.6 It was created to function as a concise summary of the lengthy JBDS manual and made pragmatically relevant for our local doctors. The overall goal was to reduce prescribing errors—both those due to missing key steps and those due to lack of logistical ‘know-how’. Laminated copies of the Prescribing Checklist were displayed prominently in the ward junior doctor’s office and on drug trolleys. The project was also presented at various local meetings including junior doctor induction, ward safety meeting and our departmental clinical governance meeting (in order to raise general awareness of the importance of adhering to perioperative VRIII guidelines and the Prescribing Checklist). The final area of intervention was an eMeds update. Changes included: (1) insertion of a reinforcing message about making appropriate changes to the patient’s insulin and other regular diabetes medicines when prescribing VRIII, (2) automating the addition of rescue medication on selection of the ‘refer to paper chart’ dummy drug and (3) rephrasing biphasic insulin descriptions to reduce confusion with other intermediate-acting insulins. The interventions were designed and implemented over a 3-month period from December 2021 to February 2022.
Publication 2023
Awareness Biphasic Insulins Clinical Governance Health Services, National Hypoglycemic Agents Insulin Patients Pharmaceutical Preparations Physicians Physicians, Junior Safety
Young people who participated in this study were users of a digital mental health service (Kooth.com). To be eligible to take part, young people had to have no previous engagement with counseling sessions within the service. Young people in the UK, commonly aged between 10 and 25 years, can access the digital mental health service online and anonymously register to receive web-based therapy services without cost. All participants for the study were required to have requested access to a synchronous text-based chat session with a practitioner in the digital service online and wait briefly until being seen by a practitioner. Data from young people were collected on the service between January 2021 and June 2021. Only data from young people using Kooth during that period who had explicitly provided research consent when using the service were available for this evaluation; no parental consent was sought for parents to preserve the safety of those aged under 16 years and anonymity during the evaluation; all users provided consent for research and evaluations at the point of registration at Kooth. Gender, age, and ethnicity were self-reported variables collected directly from the young people as part of the service sign-up process for the digital service. A service evaluation with the new measure alongside other comparator measures was deemed the best implementation approach to reduce disruption in the service (e.g., detracting people from accessing support due to research) and maintain clinical governance, as voluntary participation and information were provided prior to administering the instruments during the implementation of this instrument and the evaluation period.
Over this evaluation period, 1,401 young people accessed 1,901 chats within the service. On average, a young person accessed the chat 3.2 times during the study period (with a minimum of one and a maximum of 26 chats), and each chat lasted on average 52 min (SD = 21.6; extreme outliers removed). Young people who took part in the study were aged between 10 and 32 years, with an average age of 15.9 years (SD = 2.9). Most young people accessing the service were female (N = 1,087; 77.59%) from a white ethnic background (N = 1,111; 79.3%). In total, 1,435 (75.13%) chats included information about the participants' presenting concerns, as reported by practitioners. The majority indicated experiencing difficulties with anxiety/stress, suicidal thoughts, self-harm, and family relationships (Table 1).
Full text: Click here
Publication 2023
Anxiety Clinical Governance Ethnicity Fingers Gender Mental Health Services Parent Safety Therapeutics Vision Woman
The instrument was implemented and evaluated for a period of 6 months (January 2021 to June 2021) at Kooth.com, a web-based therapy service based in the UK, via synchronous text messaging. The service is anonymous at the point of entry and provides person-centered text-based SST or drop-in, one-at-the-time therapy that is free and accessible to CYP in most of the UK with access to an internet connection, and who wish to register and use the service.
During the evaluation period, the SWAN-OM was implemented for SSTs. A total of 120 practitioners from the web-based therapy service were recruited and trained to administer the SWAN-OM at Kooth.com. Each practitioner attended a training session of 60 min and was provided with a manual containing guidance on how to use the instrument in the platform, internal clinical governance procedures, SST relevant literature, and frequently asked questions about the instrument and the research study. Ad hoc support was provided through instant messaging software by the research group to each practitioner. All practitioners involved in the study were part of the service workforce. Therefore, practitioners were in training or had obtained their counseling or clinical qualifications as mental health practitioners. The service holds a pluralistic view on their training and therapeutic background but all within encompassing a person-centered framework to deliver care.
The SST intervention was delivered over a 40–60 min text-based chat in the online synchronous messaging system of the web-based service. The broad SST aims were to engage, conduct a brief assessment, and meet the needs of young people where possible. Brief risk assessments and safeguarding protocols were prioritized above those aims as part of service provision; these include a routine risk inquiry in every chat with questions to users explicitly asking about harm to themselves or others, and, if there is a disclosed risk, the single-session appeared will follow safety procedures as opposed to the SWAN-OM selected “Wants” and “Needs” and its processes. The approach of SST delivery by practitioners within the service was pluralistic (64 (link)) with a broad range of therapeutic orientations. The SST interventions delivered during the evaluation considered the brief-intervention mindset and its blend with traditional approaches to counseling (65 (link)), in addition to the already established evidence based on SST (13 (link), 18 (link), 66 (link)).
The SWAN-OM was administered when practitioners clicked a button in the platform to launch the questionnaires in the front-end view of the user. The battery of instruments was administered at the same points in time, before the chat (Time 1: pre-SST; PANAS and SWAN-OM) and after the chat (Time 2: post-SST; PANAS, YCIS, ESQ, and SWAN-OM).
Young people could skip the measures if they wished to at the time of accessing the service. The practitioner was able to access the item selection of the SWAN-OM at Time 1 and then start the SST when ready. Following the end of their SST chat with a practitioner, young people were asked to complete the post-session measures. Individuals who skipped the administration of the questionnaires at Time 1 were not presented with the other measures at Time 2.
Full text: Click here
Publication 2023
Brief Interventions Clinical Governance Health Risk Assessment Manpower Mental Health Mental Orientation Obstetric Delivery Safety Therapeutics
Ethics to perform this study was granted by the University of New South Wales Human Research Ethics & Clinical Trials Governance Committee (HC190924). Access to phenotypic data for all children on the autism spectrum within the AAB (n = 1151), was obtained via the Autism CRC Utilisation Grant 1.073RU.
Full text: Click here
Publication 2023
Autistic Disorder Clinical Governance Ethics Committees, Research Homo sapiens Pervasive Development Disorders Phenotype

Top products related to «Clinical Governance»

Sourced in United States, Japan, United Kingdom, Germany, Belgium, Australia, Spain, Switzerland
SPSS Statistics version 22 is a statistical software application developed by IBM. It is designed to analyze and manipulate data, providing users with tools for data management, statistical analysis, and reporting. The software supports a wide range of data types and offers a variety of statistical procedures, enabling users to explore relationships, test hypotheses, and generate insights from their data.
Sourced in United States
SPSS version 23 is a software package for statistical analysis. It provides a comprehensive set of tools for data management, analysis, and presentation. The core function of SPSS is to enable users to perform a wide range of statistical procedures, including descriptive statistics, regression analysis, and hypothesis testing.
Sourced in United States, Austria, Japan
SPSS ver. 20.0 is a software package for statistical analysis. It provides tools for data management, analysis, and presentation. The core function of SPSS is to enable users to perform a variety of statistical tests and analyses on data sets.
Sourced in Germany, France, United States, Canada, United Kingdom, Sweden, Italy, Japan
The BioRobot EZ1 is a compact, fully automated nucleic acid purification workstation designed for use in molecular biology laboratories. It utilizes magnetic-particle technology to perform fast and efficient extraction of DNA, RNA, or viral nucleic acids from a variety of sample types.
Sourced in United States, United Kingdom, Japan, Austria, Germany
SPSS Statistics for Windows, Version 25.0 is a software application designed for statistical analysis. It provides a comprehensive set of tools for data management, analysis, and visualization.
Sourced in Germany, United States, United Kingdom
The AVE buffer is a component of Qiagen's nucleic acid extraction kits. Its core function is to provide a medium for the efficient lysis and inactivation of samples, allowing the subsequent purification of nucleic acids.
Sourced in United States, Japan, United Kingdom, Austria, Germany, Czechia, Belgium, Denmark, Canada
SPSS version 22.0 is a statistical software package developed by IBM. It is designed to analyze and manipulate data for research and business purposes. The software provides a range of statistical analysis tools and techniques, including regression analysis, hypothesis testing, and data visualization.
Sourced in Germany
The EZ1 Virus minikit, version 2.0, is a lab equipment product designed for the extraction and purification of viral nucleic acids. It provides a streamlined process for isolating high-quality viral RNA or DNA from various sample types.
Sourced in United States, Norway, United Kingdom
The GE Vivid 7 is a high-performance ultrasound system designed for cardiovascular imaging. It features a compact and ergonomic design, advanced image processing capabilities, and a wide range of transducer options to support various clinical applications.

More about "Clinical Governance"

Clinical governance is a comprehensive framework that healthcare organizations utilize to ensure the quality and safety of patient care.
It encompasses a systematic approach to maintaining and enhancing clinical practices, with a strong emphasis on accountability, transparency, and continuous improvement.
Key components of clinical governance include clinical auditing, risk management, staff education and training, and the adoption of evidence-based practices.
By implementing effective clinical governance, healthcare providers can enhance patient outcomes, reduce adverse events, and promote a culture of excellence in service delivery.
This holistic approach helps organizations deliver high-quality, safe, and efficient care to the communities they serve.
Clinical governance is closely related to the statistical software SPSS (Statistical Package for the Social Sciences), which is commonly used in healthcare research and analysis.
SPSS versions 20.0, 22.0, 23, and 25.0 have been widely adopted by healthcare professionals to conduct statistical analyses, evaluate clinical data, and support evidence-based decision-making.
Additionally, tools like the BioRobot EZ1 and EZ1 Virus minikit, version 2.0, are often utilized in clinical settings for sample processing and nucleic acid extraction, contributing to the overall quality and reliability of healthcare data.
Furthermore, medical imaging equipment such as the GE Vivid 7 ultrasound system plays a crucial role in clinical governance, as it enables healthcare providers to make informed decisions based on accurate and reliable diagnostic information.
The AVE buffer, a commonly used buffer solution, also contributes to the quality and consistency of clinical procedures and laboratory analyses.
By integrating these statistical tools, laboratory equipment, and medical technologies, healthcare organizations can strengthen their clinical governance practices, enhance patient safety, and deliver more effective and efficient care to the communities they serve.
This comprehensive approach helps to foster a culture of excellence and continuous improvement in the healthcare industry.